PUBLICATION

MARVEL-domain containing CMTM4 affects CXCR4 trafficking

Authors
Bona, A., Seifert, M., Thünauer, R., Zodel, K., Frew, I.J., Römer, W., Walz, G., Yakulov, T.A.
ID
ZDB-PUB-220901-5
Date
2022
Source
Molecular biology of the cell   33(13): ar116 (Journal)
Registered Authors
Keywords
none
MeSH Terms
  • Animals
  • B7-H1 Antigen*/metabolism
  • Chemokine CXCL12/metabolism
  • Ligands
  • MARVEL Domain-Containing Proteins/metabolism
  • Mammals/metabolism
  • Proto-Oncogene Proteins c-akt/metabolism
  • Receptors, CXCR4/metabolism
  • Signal Transduction
  • Zebrafish*/metabolism
PubMed
36044337 Full text @ Mol. Biol. Cell
Abstract
The MARVEL-containing proteins CMTM4 and CMTM6 control PD-L1, thereby influencing tumor immunity. We found that defective zebrafish cmtm4 slowed the development of the posterior lateral line (pLL) by altering the Cxcr4b gradient across the pLL primordium (pLLP). Analysis in mammalian cells uncovered that CMTM4 interacted with CXCR4, altered its glycosylation pattern, but did not affect internalization or degradation of CXCR4 in the absence of its ligand CXCL12. Synchronized release of CXCR4 from the endoplasmic reticulum revealed that CMTM4 slowed CXCR4 trafficking from the endoplasmic reticulum to the plasma membrane without affecting overall cell surface expression. Altered CXCR4 trafficking reduced ligand-induced CXCR4 degradation, and affected AKT but not ERK1/2 activation. CMTM4 expression, in contrast to CXCR4, correlated to the survival of patients with renal cell cancer in the TCGA cohort. Furthermore, we observed that cmtm4 depletion promotes the separation of cells from the pLLP cell cluster in zebrafish embryos. Collectively, our findings indicate that CMTM4 exerts general roles in the biosynthetic pathway of cell surface molecules, and seems to affect CXCR4-dependent cell migration. [Media: see text] [Media: see text] [Media: see text] [Media: see text] [Media: see text].
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping